|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-6-11
|
|
pubmed:abstractText |
Self-monitoring of blood glucose (SMBG) is an important self-management tool for insulin-treated patients with Type 2 diabetes mellitus (T2DM). Its value in estimating glycaemic control in insulin-treated T2DM patients remains unclear. The relationship between glycated haemoglobin (HbA(1c)) and SMBG measures in T2DM patients treated with premixed insulin lispro mixtures or basal insulin glargine was examined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-5491
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
589-92
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20536957-Aged,
pubmed-meshheading:20536957-Blood Glucose,
pubmed-meshheading:20536957-Blood Glucose Self-Monitoring,
pubmed-meshheading:20536957-Diabetes Mellitus, Type 2,
pubmed-meshheading:20536957-Female,
pubmed-meshheading:20536957-Hemoglobin A, Glycosylated,
pubmed-meshheading:20536957-Humans,
pubmed-meshheading:20536957-Hypoglycemic Agents,
pubmed-meshheading:20536957-Insulin,
pubmed-meshheading:20536957-Insulin, Long-Acting,
pubmed-meshheading:20536957-Insulin Lispro,
pubmed-meshheading:20536957-Male,
pubmed-meshheading:20536957-Middle Aged
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
|
|
pubmed:affiliation |
Eli Lilly and Company, Indianapolis, IN 46285, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
